Chemical proteomics platform CellEKT providing physiologically relevant kinase selectivity and drug‑response profiles in cellular models for scientists developing kinase inhibitors. Delivers accurate, biologically relevant selectivity data from lead optimization through development to reduce clinical attrition and accelerate safer, more effective kinase inhibitors.